참고문헌
- Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001;163:1730-54. https://doi.org/10.1164/ajrccm.163.7.at1010
- Woodhead M, Welch CA, Harrison DA, Bellingan G, Ayres JG. Community-acquired pneumonia on the intensive care unit: secondary analysis of 17,869 cases in the ICNARC Case Mix Programme Database. Crit Care 2006;10 Suppl 2:S1.
- Siempos II, Vardakas KZ, Kopterides P, Falagas ME. Adjunctive therapies for community-acquired pneumonia: a systematic review. J Antimicrob Chemother 2008; 62:661-8. https://doi.org/10.1093/jac/dkn283
- Gogos CA, Drosou E, Bassaris HP, Skoutelis A. Proversus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis 2000;181:176-80. https://doi.org/10.1086/315214
- Bauer TT, Montón C, Torres A, Cabello H, Fillela X, Maldonado A, et al. Comparison of systemic cytokine levels in patients with acute respiratory distress syndrome, severe pneumonia, and controls. Thorax 2000; 55:46-52. https://doi.org/10.1136/thorax.55.1.46
- Salluh JI, Póvoa P, Soares M, Castro-Faria-Neto HC, Bozza FA, Bozza PT. The role of corticosteroids in severe community-acquired pneumonia: a systematic review. Crit Care 2008;12:R76. https://doi.org/10.1186/cc6922
- Annane D, Meduri GU. Corticosteroids for community- acquired pneumonia: time to act! Crit Care 2008;12:166. https://doi.org/10.1186/cc6940
- Sibila O, Agustí C, Torres A. Corticosteroids in severe pneumonia. Eur Respir J 2008;32:259-64. https://doi.org/10.1183/09031936.00154107
- Confalonieri M, Urbino R, Potena A, Piattella M, Parigi P, Puccio G, et al. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med 2005;171: 242-8. https://doi.org/10.1164/rccm.200406-808OC
- Garcia-Vidal C, Calbo E, Pascual V, Ferrer C, Quintana S, Garau J. Effects of systemic steroids in patients with severe community-acquired pneumonia. Eur Respir J 2007;30:951-6. https://doi.org/10.1183/09031936.00027607
- Salluh JI, Soares M, Coelho LM, Bozza FA, Verdeal JC, Castro-Faria-Neto HC, et al. Impact of systemic corticosteroids on the clinical course and outcomes of patients with severe community-acquired pneumonia: a cohort study. J Crit Care 2011;26:193-200. https://doi.org/10.1016/j.jcrc.2010.07.014
- Chon GR, Lim CM, Koh Y, Hong SB. Analysis of systemic corticosteroid usage and survival in patients requiring mechanical ventilation for severe community- acquired pneumonia. J Infect Chemother 2011;17: 449-55. https://doi.org/10.1007/s10156-010-0196-8
- Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243-50. https://doi.org/10.1056/NEJM199701233360402
- Koenig SM, Truwit JD. Ventilator-associated pneumonia: diagnosis, treatment, and prevention. Clin Microbiol Rev 2006;19:637-57. https://doi.org/10.1128/CMR.00051-05
- Calandra T, Cohen J; International Sepsis Forum Definition of Infection in the ICU Consensus Conference. The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med 2005;33:1538-48. https://doi.org/10.1097/01.CCM.0000168253.91200.83
- Cook D, Heyland D, Griffith L, Cook R, Marshall J, Pagliarello J. Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. Crit Care Med 1999;27:2812-7. https://doi.org/10.1097/00003246-199912000-00034
- Marik P, Kraus P, Sribante J, Havlik I, Lipman J, Johnson DW. Hydrocortisone and tumor necrosis factor in severe community-acquired pneumonia. A randomized controlled study. Chest 1993;104:389-92. https://doi.org/10.1378/chest.104.2.389
- Mikami K, Suzuki M, Kitagawa H, Kawakami M, Hirota N, Yamaguchi H, et al. Efficacy of corticosteroids in the treatment of community-acquired pneumonia requiring hospitalization. Lung 2007;185:249-55. https://doi.org/10.1007/s00408-007-9020-3
- Walters JA, Gibson PG, Wood-Baker R, Hannay M, Walters EH. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2009;(1):CD001288.
- Snijders D, Daniels JM, de Graaff CS, van der Werf TS, Boersma WG. Efficacy of corticosteroids in community- acquired pneumonia: a randomized double-blinded clinical trial. Am J Respir Crit Care Med 2010;181:975-82. https://doi.org/10.1164/rccm.200905-0808OC
- Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ, et al. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest 2007;131:954-63. https://doi.org/10.1378/chest.06-2100
- Fardet L, Kassar A, Cabane J, Flahault A. Corticosteroidinduced adverse events in adults: frequency, screening and prevention. Drug Saf 2007;30:861-81. https://doi.org/10.2165/00002018-200730100-00005
- Annane D, Sébille V, Charpentier C, Bollaert PE, François B, Korach JM, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288:862-71. https://doi.org/10.1001/jama.288.7.862